Vimarsana
Biggest News Aggregation in the World

Page 48 - Clinical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Development Today - Breaking & Trending Today

Global PLK Targeted Therapies Market Opportunity & Clinical - Vimarsana News

Global PLK Targeted Therapies Market Opportunity & Clinical

Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The

Has the battle against antipsychotic weight gain been won? - Vimarsana News

Has the battle against antipsychotic weight gain been won?

Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a potential breakthrough in combatting antipsychotic-induced weight gain (AIWG).

Interview: Wendy Cheng on global AI regulation in pharmaceuticals - Vimarsana News

Interview: Wendy Cheng on global AI regulation in pharmaceuticals

OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI regulation for pharmaceuticals, clinical trials, and drug development at a global scale.

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023 - Vimarsana News

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023

•   Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting •   Execution of strategic...

Key opinion leaders on GLP-1 receptor agonist clinical trial design - Vimarsana News

Key opinion leaders on GLP-1 receptor agonist clinical trial design

Representing the real-world population in clinical trials is one of the most important factors in clinical studies.

Source: yahoo.com